# Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection

> **NCT00098046** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 76 (estimated)

## Conditions studied

- Chickenpox
- Herpes Zoster

## Interventions

- **DRUG:** famciclovir

## Key facts

- **NCT ID:** NCT00098046
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-07
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2007-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00098046

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00098046, "Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00098046. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*